Interactive and Multifactorial Mechanisms of Calcific Vascular and Valvular Disease

Publication date: Available online 3 July 2019Source: Trends in Endocrinology & MetabolismAuthor(s): Linda L. Demer, Yin TintutCalcific vascular and valvular disease (CVVD) is widespread and has major health consequences. Although coronary artery calcification has long been associated with hyperlipidemia and increased mortality, recent evidence suggests that its progression is increased in association with cholesterol-lowering HMG-CoA reductase inhibitors (‘statins’) and long-term, high-intensity exercise. A nationwide trial showed no cardiovascular benefit of vitamin D supplements. Controversy remains as to whether calcium deposits in plaque promote or prevent plaque rupture. CVVD appears to occur through mechanisms similar to those of intramembranous, endochondral, and osteophytic skeletal bone formation. New evidence implicates autotaxin, endothelial–mesenchymal transformation, and microRNA and long non-coding RNA (lncRNA) as novel regulatory factors. New therapeutic options are being developed.
Source: Trends in Endocrinology and Metabolism - Category: Endocrinology Source Type: research